Basic Information
| RNALocate ID: | RLID:11003861 |
| RNA Symbol: | hsa-miR-34b-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-34b-3p |
| RNA ID: | miRBase:MIMAT0004676 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003860 | Exosome | Serum | 18589210 |
| RLID:11003862 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11003863 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:11003864 | Microvesicle | Serum | 24797360 |
| RLID-D:11000652 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001525 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-34b-3p | Oral squamous cell carcinoma | MNDR-E-MI-42814 |
| MNDR | hsa-miR-34b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-42815 |
| MNDR | hsa-miR-34b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-42816 |
| MNDR | hsa-miR-34b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-42817 |
| MNDR | hsa-miR-34b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-42818 |
| MNDR | hsa-miR-34b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-42819 |
| MNDR | hsa-miR-34b-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-42820 |
| MNDR | hsa-miR-34b-3p | Prostate cancer | MNDR-E-MI-42821 |
| MNDR | hsa-miR-34b-3p | Alzheimer disease | MNDR-E-MI-42822 |
| MNDR | hsa-miR-34b-3p | Intracranial aneurysm | MNDR-E-MI-42823 |
| MNDR | hsa-miR-34b-3p | Myotonic dystrophy | MNDR-E-MI-42824 |
| MNDR | hsa-miR-34b-3p | Head and neck cancer | MNDR-E-MI-42825 |
| MNDR | hsa-miR-34b-3p | Huntington disease | MNDR-E-MI-42826 |
| MNDR | hsa-miR-34b-3p | Chorea | MNDR-E-MI-42827 |
| MNDR | hsa-miR-34b-3p | Lung cancer | MNDR-E-MI-42828 |
| MNDR | hsa-miR-34b-3p | Parkinson disease | MNDR-E-MI-42829 |
| MNDR | hsa-miR-34b-3p | Machado-joseph disease | MNDR-E-MI-42830 |
| MNDR | hsa-miR-34b-3p | Breast cancer | MNDR-E-MI-42831 |
| MNDR | hsa-miR-34b-3p | Pituitary neoplasms | MNDR-E-MI-42832 |
| MNDR | hsa-miR-34b-3p | Pancreatic cancer | MNDR-E-MI-42833 |
| MNDR | hsa-miR-34b-3p | Colon cancer | MNDR-E-MI-42834 |
| MNDR | hsa-miR-34b-3p | Familial ovarian cancer | MNDR-E-MI-42835 |
| MNDR | hsa-miR-34b-3p | Carcinoma ductal breast | MNDR-E-MI-42836 |
| MNDR | hsa-miR-34b-3p | Glioblastoma | MNDR-E-MI-42837 |
| MNDR | hsa-miR-34b-3p | Glioma | MNDR-E-MI-42838 |
| MNDR | hsa-miR-34b-3p | Epilepsy temporal lobe | MNDR-E-MI-42839 |
| MNDR | hsa-miR-34b-3p | Liposarcoma | MNDR-E-MI-42840 |
| MNDR | hsa-miR-34b-3p | Uterine cancer | MNDR-E-MI-42841 |
| MNDR | hsa-miR-34b-3p | Lung squamous cell carcinoma | MNDR-E-MI-42842 |
| MNDR | hsa-miR-34b-3p | Lung adenocarcinoma | MNDR-E-MI-42843 |
| MNDR | hsa-miR-34b-3p | Thyroid carcinoma | MNDR-E-MI-42844 |
| MNDR | hsa-miR-34b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-42845 |
| MNDR | hsa-miR-34b-3p | Clear cell renal cell carcinoma | MNDR-E-MI-42846 |
| MNDR | hsa-miR-34b-3p | Cholangiocarcinoma | MNDR-E-MI-42847 |
| MNDR | hsa-miR-34b-3p | Esophageal cancer | MNDR-E-MI-42848 |
| MNDR | hsa-miR-34b-3p | Lung small cell carcinoma | MNDR-E-MI-42849 |
| MNDR | hsa-miR-34b-3p | Synovial sarcoma | MNDR-E-MI-42850 |
| MNDR | hsa-miR-34b-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-42851 |
| MNDR | hsa-miR-34b-3p | Breast invasive carcinoma | MNDR-E-MI-42852 |
| MNDR | hsa-miR-34b-3p | Hepatocellular carcinoma | MNDR-E-MI-42853 |
| MNDR | hsa-miR-34b-3p | Familiar ovarian carcinoma | MNDR-E-MI-42854 |
| MNDR | hsa-miR-34b-3p | Malignant pleural mesothelioma | MNDR-E-MI-42855 |
| MNDR | hsa-miR-34b-3p | Barrett's adenocarcinoma | MNDR-E-MI-42856 |
| MNDR | hsa-miR-34b-3p | Burkitt lymphoma | MNDR-E-MI-42857 |
| MNDR | hsa-miR-34b-3p | Colorectal cancer | MNDR-E-MI-42858 |
| MNDR | hsa-miR-34b-3p | Nasopharynx carcinoma | MNDR-E-MI-42859 |
| MNDR | hsa-miR-34b-3p | Acute lymphocytic leukemia | MNDR-E-MI-42860 |
| MNDR | hsa-miR-34b-3p | Nasopharyngeal cancer | MNDR-E-MI-42861 |
| MNDR | hsa-miR-34b-3p | Barrett's carcinogenesis | MNDR-E-MI-42862 |
| MNDR | hsa-miR-34b-3p | Breast cancer her3+ negative | MNDR-E-MI-42863 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AXL | Homo sapiens | RR00168797 |
TOP